IPO registrations (S-1, F-1) · Registrants
Vireo Growth Inc.
- SEC CIK
- 1771706 · filings on EDGAR ↗
- Name on the registration
- Goodness Growth Holdings, Inc.
- Former names
- Goodness Growth Holdings, Inc. (2021–2024); Vireo Health International, Inc. (2019–2021)
- Registration
- Form S-1, first filed 2023-08-04; 1 initial registration, 0 amendments
- Outcome
- Declared effective 2023-08-10
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- A1
- Business address
- 207 SOUTH 9TH STREET, Minneapolis, MN 55402
- Ticker
- VREOF (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Vireo Growth Inc. on the corporate pages
On this site
- Form D issuer: Vireo Growth Inc. EXACT (CIK (EXACT))
- SEC filer: Goodness Growth Holdings, Inc. EXACT (CIK (EXACT))
Filings 4
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2023-08-04 | S-1 | S-1 (registration) | Goodness Growth Holdings, Inc. | 0001410578-23-001557 ↗ |
| 2023-08-10 | EFFECT | EFFECT (declared effective) | Goodness Growth Holdings, Inc. | 9999999995-23-002347 ↗ |
| 2024-10-24 | EFFECT | EFFECT (declared effective) | Vireo Growth Inc. | 9999999995-24-003270 ↗ |
| 2025-07-24 | EFFECT | EFFECT (declared effective) | Vireo Growth Inc. | 9999999995-25-002353 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-04 | S-1 | registration statement | $0.14 | - | - | OTCQX GDNSF | 0 | primary document; price line | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Dahmer Stephen | Officer | Chief Medical Officer; CHIEF MEDICAL OFFICER | 2 | 2021–2022 | |
| Heller John Andrew | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 4 | 2021–2023 | |
| Hussey Ross Michael | Director | 6 | 2021–2026 | ||
| Kingsley Kyle Eugene | Director,Officer; Director,Officer,TenPercentOwner; Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER; Co-Executive Chairman; Executive Chairman | 6 | 2021–2025 | |
| Nordquist Judd Theodore | Director | 8 | 2021–2026 | ||
| Ocasio Christian Gonzales | Officer | Chief Operating Officer; CHIEF OPERATING OFFICER | 2 | 2021–2022 | |
| Peters Patrick | Officer | EVP of Retail; EVP OF RETAIL | 3 | 2021–2022 | |
| Shimpa Amber Holly | Director,Officer; Officer | CEO and President; Chief Administrative Officer; CHIEF ADMINISTRATIVE OFFICER; President; PRESIDENT & CORP. SECRETARY | 7 | 2021–2025 | |
| GRAYSON CHELSEA A | Director | 5 | 2021–2022 | ||
| Schroeder J Michael | Officer | General Counsel & CCO; GENERAL COUNSEL & CCO | 4 | 2021–2023 | |
| Mancebo Victor E. | Director | 7 | 2021–2026 | ||
| Rosen Joshua | Director; Director,Officer; Other | CEO and Interim CFO; Chief Executive Officer; INTERIM PRESIDENT | 6 | 2021–2025 | |
| Chicago Atlantic Advisers, LLC | TenPercentOwner | 20 | 2023–2025 | ||
| Chicago Atlantic Credit Opportunities, LLC | TenPercentOwner | 10 | 2023–2025 | ||
| Chicago Atlantic GP Holdings, LLC | TenPercentOwner | 20 | 2023–2025 | ||
| Chicago Atlantic Group GP, LLC | TenPercentOwner | 20 | 2023–2025 | ||
| Chicago Atlantic Group, LP | TenPercentOwner | 20 | 2023–2025 | ||
| Chicago Atlantic Manager, LLC | TenPercentOwner | 19 | 2023–2025 | ||
| Chicago Atlantic Opportunity GP, LLC | TenPercentOwner | 18 | 2024–2025 | ||
| Chicago Atlantic Opportunity Portfolio, LP | TenPercentOwner | 18 | 2024–2025 | ||
| Duxbury Joseph | Officer; Other | Chief Accounting Officer; Interim CFO | 5 | 2024–2026 | |
| Mazarakis John | Director,Officer | Chief Executive Officer | 4 | 2024–2025 | |
| Macdonald Tyson | Officer | Chief Financial Officer | 5 | 2024–2025 | |
| Apfelbaum Sean Michael | Officer | GC and Corporate Secretary | 4 | 2025–2026 | |
| Steiner Michael L. | Director | 1 | 2026 | ||
| Hagedorn Christopher | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-08-24 | Vireo Growth Inc. | Other | $48,676,969 | $47,676,969 | 27 | 1 |
| 2026-06-29 | Vireo Growth Inc. | Other | $1,149,959 | $1,149,959 | 3 | 1 |
| 2026-06-22 | Vireo Growth Inc. | Other | $13,662,648 | $13,662,648 | 7 | 1 |
| 2026-04-22 | Vireo Growth Inc. | Other | $195,800,000 | $127,800,000 | 1 | 1 |
| 2026-04-16 | Vireo Growth Inc. | Other | $50,612,571 | $50,612,571 | 19 | 1 |
| 2026-01-12 | Vireo Growth Inc. | Other | $1,672,591 | $1,672,591 | 9 | 1 |
| 2025-10-23 | Vireo Growth Inc. | Other | $61,996,221 | $61,996,221 | 22 | 1 |
| 2025-07-18 | Vireo Growth Inc. | Other | $10,000,000 | $10,000,000 | 1 | 1 |
| 2025-01-07 | Vireo Growth Inc. | Other | $80,960,547 | $80,960,547 | 41 | 1 |
| 2024-11-12 | Vireo Growth Inc. | Other | $10,000,000 | $10,000,000 | 1 | 1 |
| 2024-08-20 | Vireo Growth Inc. | Other | $5,387,500 | $5,387,500 | 14 | 1 |
| 2023-08-10 | Goodness Growth Holdings, Inc. | Pharmaceuticals | $10,000,000 | $0 | 2 | 1 |
| 2023-08-10 | Goodness Growth Holdings, Inc. | Pharmaceuticals | $90,625 | $90,625 | 6 | 1 |
| 2020-03-23 | Vireo Health International, Inc. | Other | $5,976,474 | $2,660,049 | 8 | 1 |
| 2019-04-01 | Vireo Health International, Inc. | Other | $14,951,333 | $14,951,333 | 68 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Vireo Growth Inc. | MN | Form D private offerings | CIK (EXACT) |
| SEC filer | Vireo Growth Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MN first:
- LIFECORE BIOMEDICAL, INC. \DE\ MN
- Panbela Therapeutics, Inc. MN
- DiaMedica Therapeutics Inc. MN
- Enterologics, Inc. MN
- Squarex Pharmaceutical Corp MN
- Life Science Holdings, Inc. MN
- CIMA LABS INC MN
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
In other datasets, the same topic (Health) in MN:
- Nonprofit: ABBOTT NORTHWESTERN HOSPITAL FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health